WO2006054262A3 - Use of phage display technique for identifying peptides capable of binding progenitor/stem cells, peptides thereby obtained and uses thereof - Google Patents
Use of phage display technique for identifying peptides capable of binding progenitor/stem cells, peptides thereby obtained and uses thereof Download PDFInfo
- Publication number
- WO2006054262A3 WO2006054262A3 PCT/IB2005/053811 IB2005053811W WO2006054262A3 WO 2006054262 A3 WO2006054262 A3 WO 2006054262A3 IB 2005053811 W IB2005053811 W IB 2005053811W WO 2006054262 A3 WO2006054262 A3 WO 2006054262A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- peptides
- stem cells
- phage display
- display technique
- progenitor
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B40/00—Libraries per se, e.g. arrays, mixtures
- C40B40/02—Libraries contained in or displayed by microorganisms, e.g. bacteria or animal cells; Libraries contained in or displayed by vectors, e.g. plasmids; Libraries containing only microorganisms or vectors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1037—Screening libraries presented on the surface of microorganisms, e.g. phage display, E. coli display
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Physics & Mathematics (AREA)
- Virology (AREA)
- Plant Pathology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITRM2004A000568 | 2004-11-18 | ||
ITRM20040568 ITRM20040568A1 (en) | 2004-11-18 | 2004-11-18 | USE OF THE "PHAGE DISPLAY" TECHNIQUE FOR THE IDENTIFICATION OF PEPTIDES WITH CAPACITY OF STAMIN CELLS / PROGENITOR, PEPTIDES SO OBTAINED AND THEIR USES. |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2006054262A2 WO2006054262A2 (en) | 2006-05-26 |
WO2006054262A3 true WO2006054262A3 (en) | 2006-10-05 |
Family
ID=36407529
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2005/053811 WO2006054262A2 (en) | 2004-11-18 | 2005-11-18 | Use of phage display technique for identifying peptides capable of binding progenitor/stem cells, peptides thereby obtained and uses thereof |
Country Status (2)
Country | Link |
---|---|
IT (1) | ITRM20040568A1 (en) |
WO (1) | WO2006054262A2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9528109B2 (en) | 2007-10-26 | 2016-12-27 | Biomarin Technologies B.V. | Methods and means for efficient skipping of exon 45 in duchenne muscular dystrophy pre-mRNA |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2049664B1 (en) | 2006-08-11 | 2011-09-14 | Prosensa Technologies B.V. | Single stranded oligonucleotides complementary to repetitive elements for treating DNA repeat instability associated genetic disorders |
US8501905B2 (en) | 2007-03-22 | 2013-08-06 | The Regents Of The University Of California | Synthetic cell platforms and methods of use thereof |
EP1985708B1 (en) * | 2007-04-27 | 2015-04-15 | Universität Rostock | Selective targeting of viruses to neural precursor cells |
WO2009008725A2 (en) | 2007-07-12 | 2009-01-15 | Prosensa Technologies B.V. | Molecules for targeting compounds to various selected organs, tissues or tumor cells |
NZ582521A (en) | 2007-07-12 | 2011-09-30 | Prosensa Technologies Bv | A conjugate comprising the amino acid sequence LGAQSNF for targeting compounds to muscle tissue |
USRE48468E1 (en) | 2007-10-26 | 2021-03-16 | Biomarin Technologies B.V. | Means and methods for counteracting muscle disorders |
NZ587178A (en) | 2008-02-08 | 2011-11-25 | Prosensa Holding Bv | Methods and means for treating dna repeat instability associated genetic disorders |
EP2119783A1 (en) | 2008-05-14 | 2009-11-18 | Prosensa Technologies B.V. | Method for efficient exon (44) skipping in Duchenne Muscular Dystrophy and associated means |
US20110003702A1 (en) * | 2009-06-03 | 2011-01-06 | President And Fellows Of Harvard College | Methods, systems, and kits for identification of osteoinductive peptides |
WO2010123369A1 (en) | 2009-04-24 | 2010-10-28 | Prosensa Technologies B.V. | Oligonucleotide comprising an inosine for treating dmd |
WO2013009690A2 (en) | 2011-07-09 | 2013-01-17 | The Regents Of The University Of California | Leukemia stem cell targeting ligands and methods of use |
CN104203289B (en) | 2012-01-27 | 2020-11-03 | 比奥马林技术公司 | RNA-regulatory oligonucleotides with improved properties for the treatment of duchenne muscular dystrophy and becker muscular dystrophy |
US9175263B2 (en) * | 2012-08-22 | 2015-11-03 | Biotime, Inc. | Methods and compositions for targeting progenitor cell lines |
CN113648323A (en) | 2013-06-05 | 2021-11-16 | 再生疗法有限公司 | Compositions and methods for induced tissue regeneration in mammalian species |
CN103497236B (en) * | 2013-09-25 | 2017-05-10 | 浙江省医学科学院 | Specific heptapeptide targeting to WISP-1 protein and application thereof |
US10240127B2 (en) | 2014-07-03 | 2019-03-26 | ReCyte Therapeutics, Inc. | Exosomes from clonal progenitor cells |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002020822A2 (en) * | 2000-09-08 | 2002-03-14 | Board Of Regents, The University Of Texas System | Biopanning and rapid analysis of selective interactive ligands (brasil) |
US20030219826A1 (en) * | 1999-09-01 | 2003-11-27 | Robbins Paul D. | Identification of peptides that facilitate uptake and cytoplasmic and/or nuclear transport of proteins, DNA and viruses |
-
2004
- 2004-11-18 IT ITRM20040568 patent/ITRM20040568A1/en unknown
-
2005
- 2005-11-18 WO PCT/IB2005/053811 patent/WO2006054262A2/en active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030219826A1 (en) * | 1999-09-01 | 2003-11-27 | Robbins Paul D. | Identification of peptides that facilitate uptake and cytoplasmic and/or nuclear transport of proteins, DNA and viruses |
WO2002020822A2 (en) * | 2000-09-08 | 2002-03-14 | Board Of Regents, The University Of Texas System | Biopanning and rapid analysis of selective interactive ligands (brasil) |
Non-Patent Citations (1)
Title |
---|
BARRY ET AL: "Towards cell-targeting gene therapy vectors: selection of cell-binding peptids from random peptide-presenting phage libraries", NATURE MEDICINE, NATURE PUBLISHING GROUP, NEW YORK, NY, US, vol. 2, no. 3, March 1996 (1996-03-01), pages 299 - 305, XP002086381, ISSN: 1078-8956 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9528109B2 (en) | 2007-10-26 | 2016-12-27 | Biomarin Technologies B.V. | Methods and means for efficient skipping of exon 45 in duchenne muscular dystrophy pre-mRNA |
Also Published As
Publication number | Publication date |
---|---|
ITRM20040568A1 (en) | 2005-02-18 |
WO2006054262A2 (en) | 2006-05-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2006054262A3 (en) | Use of phage display technique for identifying peptides capable of binding progenitor/stem cells, peptides thereby obtained and uses thereof | |
RU2016146198A (en) | THERAPEUTIC DLL4-BINDING PROTEINS | |
WO2007149062A3 (en) | Bioactive fus1 peptides and nanoprticle-polypeptide complexes | |
WO2010011313A3 (en) | Ligation of stapled polypeptides | |
WO2007039231A3 (en) | Method of producing a modified (poly)peptide | |
WO2009004315A8 (en) | Isolated peptides and uses thereof | |
WO2006135793A3 (en) | Protein engineering with analogous contact environments | |
WO2017025179A8 (en) | A transglutamine tag for efficient site-specific bioconjugation | |
WO2006046239A3 (en) | A thymus-specific protein | |
WO2007029262A3 (en) | Compositions and methods using same for the detection of viruses | |
WO2008113536A8 (en) | Neurotrophic peptides | |
WO2006086607A3 (en) | Novel proteins with enhanced functionality and methods of making novel proteins using circular permutation | |
EP1842911A4 (en) | Hla-binding peptides, dna fragments encoding the same and recombinant vectors | |
WO2006075253A3 (en) | Peptides for desensitizing subjects allergic to dog hair and dander and compositions containing said peptides. | |
NZ601647A (en) | Variant hhip1 protein and methods and uses thereof | |
WO2008157380A3 (en) | Chemically modified cyclic peptides containing cell adhesion recognition (car) sequences and uses therefor | |
WO2008142664A3 (en) | Exposed thymidine kinase 1 peptides, ligands and methods employing the same | |
WO2005072766A3 (en) | Peptides that bind to hsp90 proteins | |
EP1757687A4 (en) | Hla-binding peptide, precursor thereof, dna fragment encoding the same and recombinant vector | |
WO2012015979A3 (en) | Hmgb1-derived peptides enhance immune response to antigens | |
WO2005000870A3 (en) | Isolated ny-eso-1 peptides which bind to hla class ii molecules and uses thereof | |
WO2007066018A3 (en) | Novel peptides and the biological use thereof | |
EP1801211A4 (en) | Hla-binding peptide, dna fragment encoding the same and recombinant vector | |
WO2002040683A3 (en) | Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof | |
WO2007075845A3 (en) | Isolated mcpip and methods of use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KN KP KR KZ LC LK LR LS LT LU LV LY MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 05812026 Country of ref document: EP Kind code of ref document: A2 |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 05812026 Country of ref document: EP Kind code of ref document: A2 |